Table of Contents (20 articles)

Cancer drug resistance: a new perspective

Godefridus J. Peters

View Full-Text Download PDF Pages 1-5

How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?

Adrian C. Jaramillo, ... Godefridus J. Peters

View Full-Text Download PDF Pages 6-29

Identification and targeting of CD22ΔE12 as a molecular RNAi target to overcome drug resistance in high-risk B-lineage leukemias and lymphomas

Fatih M. Uckun, Sanjive Qazi

View Full-Text Download PDF Pages 30-47

Improved potency of F10 relative to 5-fluorouracil in colorectal cancer cells with p53 mutations

Anthony Dominijanni, William H. Gmeiner

View Full-Text Download PDF Pages 48-58

Reduction of mitomycin C resistance in human bladder cancer T24 cells by knocking-down ras oncogene

Osama Sharaf Eldin, ... Kate E. Williamson

View Full-Text Download PDF Pages 59-71

Resistance mechanism to cisplatin in NCI-H460 non-small cell lung cancer cell line: investigating apoptosis, autophagy, and cytogenetic damage

Érica Ballestreri, ... Ivana Grivicich

View Full-Text Download PDF Pages 72-81

Targeted therapies in cancer: where are we going?

Elisa Giovannetti, Jose A. Rodriguez

View Full-Text Download PDF Pages 82-86

Drug targets and resistance mechanisms in multiple myeloma

Janine Nass, Thomas Efferth

View Full-Text Download PDF Pages 87-117

Linking tyrosine kinase inhibitor-mediated inflammation with normal epithelial cell homeostasis and tumor therapeutic responses

Natalia J. Gurule, Lynn E. Heasley

View Full-Text Download PDF Pages 118-125

Glutamine metabolism in cancer therapy

Tra-Ly Nguyen, Raúl V. Durán

View Full-Text Download PDF Pages 126-138

Hitting a moving target: inhibition of the nuclear export receptor XPO1/CRM1 as a therapeutic approach in cancer

Maria Sendino, ... Jose Antonio Rodríguez

View Full-Text Download PDF Pages 139-163

Molecular bases of Sorcin-dependent resistance to chemotherapeutic agents

Ilaria Genovese, ... Gianni Colotti

View Full-Text Download PDF Pages 164-180

Sphingolipid metabolism and drug resistance in ovarian cancer

Kelly M. Kreitzburg, ... Karina J. Yoon

View Full-Text Download PDF Pages 181-197

Acknowledgement to reviewers of Cancer Drug Resistance in 2018

Cancer Drug Resistance Editorial Office

View Full-Text Download PDF Pages 198-199

What really matters - response and resistance in cancer therapy

Tim R. Fenton, ... Martin Michaelis

View Full-Text Download PDF Pages 200-203

Antibody drug conjugate development in gastrointestinal cancers: hopes and hurdles from clinical trials

Xiaorong Wu, ... Ian Chau

View Full-Text Download PDF Pages 204-218

Epigenetics, a key player of immunotherapy resistance

Paul Peixoto, ... Eric Hervouet

View Full-Text Download PDF Pages 219-229

Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer

Nele Van Der Steen, ... Godefridus J. Peters

View Full-Text Download PDF Pages 230-249

Wilms’ tumor gene (WT1) is strongly expressed in high-risk subsets of pediatric acute lymphoblastic leukemia

Fatih M. Uckun, Sanjive Qazi

View Full-Text Download PDF Pages 250-265

Meeting Abstracts of the BACR conference: response and resistance in cancer therapy

View Full-Text Download PDF Pages 266-302

Actions for 0 selected articles